<DOC>
	<DOCNO>NCT01862835</DOCNO>
	<brief_summary>Repletion testosterone ( T ) old men drive Growth Hormone secretion aromatization estradiol ( E2 ) potentiate endogenous GH drive .</brief_summary>
	<brief_title>Impact Estradiol Addback</brief_title>
	<detailed_description>Systemic concentration Te , E2 , GH , Insulin-like Growth Factor-I IGFBP-3 decline healthy age men . Relative sex-steroid deprivation accentuate GH IGF-I depletion , since Te stimulate GH IGF-I production old men , hypogonadal male age , patient undergo ( genotypic female-to-male ) gender reassignment . Tamoxifen block effect Te , suggest involvement E2 GH 's stimulation men . E2 per se stimulates GH secretion woman . Because Te convert E2 aromatization body , postulate E2 active moiety men also . Moreover , hypothesize decline E2 old men contribute fall GH output . This never test . From clinical vantage , understand mechanistic basis Te 's drive somatotropic axis especially relevant boy pubertal failure , adult primary hypogonadism men aging-related hypoandrogenemia . In relation age male , testosterone E2 bioavailabilities fall 35-50 % eighth compare third decade life . From medical perspective , age accompany progressive osteopenia , sarcopenia intra-abdominal obesity . These adverse outcome remediable short-term replacement Te and/or recombinant GH , thus link GH/Te/E2 availability key body-compositional feature .</detailed_description>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Inclusion : 60 healthy men ( age 60 80 ) ; BMI 1830 kg/m2 Community dwelling ; voluntarily consent Exclusion : Recent use psychotropic neuroactive drug ( within five biological halflive ) ; Obesity ( outside weight range ) ; Laboratory test result deem physician acceptable , cholesterol &gt; 250 , triglyceride &gt; 300 , BUN &gt; 30 creatinine &gt; 1.5 mg/dL , liver function test twice upper limit normal , electrolyte abnormality , anemia ; hemoglobin &lt; 12.0 gm/dL Drug alcohol abuse , psychosis , depression , mania severe anxiety ; Acute chronic organsystem disease ; Endocrinopathy , primary thyroidal failure receive replacement ; untreated osteoporosis Nightshift work recent transmeridian travel ( exceed 3 time zone within 7 day admission ) ; Acute weight change ( loss gain &gt; 2 kg 6 week ) ; Allergy peanut oil ( use injectable Te preparation ) Unwillingness provide write informed consent . PSA &gt; 4.0 ng/mL History suspicion prostatic disease ( elevated PSA , indeterminate nodule mass , obstructive uropathy . History carcinoma ( exclude localize basal cell carcinoma remove surgically treat recurrence . History thrombotic arterial disease ( stroke , TIA , MI , angina ) deep vein thrombophlebitis . History CHF , cardiac arrhythmia , congential QT prolongation , medication use treat cardiac arrhythmia Gynecomastia &gt; 2 cm , untreated Untreated gallbladder disease History smoking great one ppd .</criteria>
	<gender>Male</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>